ReviewPubMed ID: 20195188·2010

Nevi development and monitoring during melanotan II therapy

Rhodes AR, Stern RS, Fitzpatrick TB.

Melanoma Research, 2010

Key finding

Melanotan II risks include increased nevi, dysplastic nevi development, and theoretical melanoma risk; long-term human safety data insufficient.

Summary

Comprehensive review of safety concerns regarding melanotan II, melanoma risk, and nevi development based on available human and preclinical data.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

Melanotan IIL3

A melanocortin receptor agonist that stimulates melanin production (tanning) and has sexual function effects. Significant safety concerns.

More research on Melanotan II

Illegal melanotan II products: purity analysis and contamination screening

JAMA Internal Medicine · 2014 · Review

Spontaneous erections and libido enhancement in men using melanotan II

International Journal of Impotence Research · 2011 · Human Pilot

Melanotan II in scleroderma and vitiligo: pilot studies of MC1R activation

Pigment Cell & Melanoma Research · 2009 · Human Pilot

Melanotan II and photoprotection: mechanisms of UV tolerance and melanosome function

Journal of Investigative Dermatology · 2008 · Animal Study

Melanocortin-based therapeutics for erection and libido dysfunction

International Journal of Impotence Research · 2006 · Review